VXLLF (Vaxil Bio) Shiller PE Ratio: (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VXLLF Vaxil Bio Ltd VXLLF
35 GF Score
Price $0.11
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vaxil Bio  (OTCPK:VXLLF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vaxil Bio Shiller PE Ratio Related Terms


Vaxil Bio Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio Shiller PE Ratio Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vaxil Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VXLLF vs VRTX, REGN, MRNA: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Vaxil Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Shiller PE Ratio falls into.


VXLLF
35GF Score
Vaxil Bio Ltd VXLLF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vaxil Bio's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Vaxil Bio's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.011/133.5265*133.5265
=-0.011

Current CPI (Jun. 2026) = 133.5265.

Vaxil Bio Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.381 101.765 -0.500
201612 -0.750 101.449 -0.987
201703 -0.373 102.634 -0.485
201706 -0.376 103.029 -0.487
201709 -0.407 103.345 -0.526
201712 -0.783 103.345 -1.012
201803 -0.121 105.004 -0.154
201806 -0.381 105.557 -0.482
201809 -0.384 105.636 -0.485
201812 0.000 105.399 0.000
201903 -0.106 106.979 -0.132
201906 -0.086 107.690 -0.107
201909 -0.088 107.611 -0.109
201912 0.000 107.769 0.000
202003 -0.068 107.927 -0.084
202006 -0.369 108.401 -0.455
202009 -0.378 108.164 -0.467
202012 0.000 108.559 0.000
202103 -0.077 110.298 -0.093
202106 -0.409 111.720 -0.489
202109 -0.069 112.905 -0.082
202112 -0.185 113.774 -0.217
202203 -0.036 117.646 -0.041
202206 -0.042 120.806 -0.046
202209 -0.038 120.648 -0.042
202212 -0.258 120.964 -0.285
202303 -0.365 122.702 -0.397
202306 -0.035 124.203 -0.038
202309 -0.008 125.230 -0.009
202312 0.002 125.072 0.002
202403 -0.015 126.258 -0.016
202406 0.000 127.522 0.000
202409 -0.013 127.285 -0.014
202412 -0.005 127.364 -0.005
202503 -0.018 129.181 -0.019
202506 0.011 129.892 0.011
202509 -0.007 130.287 -0.007
202512 0.146 130.366 0.150
202603 -0.020 132.262 -0.020
202606 -0.011 133.527 -0.011

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vaxil Bio Business Description

Other Exchanges VXL:Canada
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
35GF Score

Get the complete analysis for VXLLF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price